Transcription of Addressing specific regulatory excipient …
{{id}} {{{paragraph}}}
Addressing specific regulatory excipientrequirements in the marketing authorizationAddressing specific regulatory excipientrequirements in the marketing authorizationDr. Philipp HebestreitGlobal regulatory AffairsPharma Ingredients & ServicesBASF SEPharmSciFair Nice, June 11th, 2009Dr. Philipp Hebestreit, Pharma Ingredients & Services, BASF SEPresentation PharmSciFair of excipient vs. API registrationzClassification of excipientszExcipient guidancezRegistration challenges of well-known vs. new excipientszThe basis for successful registration: excipient master fileszSafety assessment of excipientszHot topicszIndustry concernszCase study: Registration of a novel excipientzSummary & conclusionDr.
Addressing specific regulatory excipient requirements in the marketing authorization Dr. Philipp Hebestreit Global Regulatory Affairs Pharma Ingredients & Services
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}